$ZIMV News
Last published 1y ago
- 1y agoZIMVZimVie Announces Completion of its Acquisition by ARCHIMEDGlobeNewswirePALM BEACH GARDENS, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. ("ZimVie"), a global life sciences leader in the dental implant market, today announced that ARCHIMED, an investment firm focused exclusively on
- 1y agoZIMVZimVie Stockholders Vote to Approve Acquisition by ARCHIMEDGlobeNewswirePALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. ("ZimVie") (NASDAQ:ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders
- 1y agoZIMVZimVie Reports Second Quarter 2025 Financial ResultsGlobeNewswireRecently entered into definitive agreement to be acquired by ARCHIMED for $19.00 in cash per shareNet Sales from Continuing Operations of $116.7 millionNet Loss from Continuing Operations of $(3.8) million; Net Loss
- 1y agoZIMVZimVie to Report Second Quarter 2025 Financial Results on July 30, 2025GlobeNewswirePALM BEACH GARDENS, Fla., July 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced it will report financial results for the second quarter
- 1y agoZIMVZimVie Announces Exclusive Distribution Agreement with Osstem Implant to Expand Premium Dental Implant Offering in ChinaGlobeNewswirePALM BEACH GARDENS, Fla., July 23, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced a strategic distribution agreement with Osstem Implant
- 1y agoZIMVZimVie Announces Definitive Agreement to be Acquired by ARCHIMED for $19.00 Per Share in CashGlobeNewswirePALM BEACH GARDENS, Fla., July 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. ("ZimVie") (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced their entry into a definitive agreement
- 1y agoZIMVZimVie Announces Launch of RealGUIDE® Dental Implant Software Suite and Implant Concierge® Service in JapanGlobeNewswirePALM BEACH GARDENS, Fla., June 05, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its RealGUIDE® Software Suite and
- 1y agoZIMVZimVie to Participate in the Stifel 2025 Jaws & Paws ConferenceGlobeNewswirePALM BEACH GARDENS, Fla., May 14, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming Stifel 2025 Jaws
- 1y agoZIMVZimVie Reports First Quarter 2025 Financial ResultsGlobeNewswireNet Sales from Continuing Operations of $112.0 millionNet Loss from Continuing Operations of $(2.6) million; Net Loss margin of (2.3)% Adjusted EBITDA[1] from Continuing Operations of $17.6 million; Adjusted EBITDA[1]
- 1y agoZIMVZimVie to Report First Quarter 2025 Financial Results on May 8, 2025GlobeNewswirePALM BEACH GARDENS, Fla., April 24, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2025
- 1y agoZIMVZimVie Pioneers the Future of Molar Restoration with New Immediate Molar Dental Implant SystemGlobeNewswirePALM BEACH GARDENS, Fla., April 21, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced the launch of its Immediate Molar Implant System in
- 1y agoZIMVZimVie to Participate in the 24th Annual Needham Virtual Healthcare ConferenceGlobeNewswirePALM BEACH GARDENS, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming 24th Annual
- 1y agoZIMVZimVie Announces Upcoming Changes to Company's Board of DirectorsGlobeNewswirePALM BEACH GARDENS, Fla., March 13, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced upcoming changes to the Company's Board of
- 1y agoZIMVZimVie Reports Fourth Quarter and Full Year 2024 Financial ResultsGlobeNewswireFY2024 Third Party Net Sales from Continuing Operations of $449.7 millionFY2024 Net Loss from Continuing Operations of $(33.8) million; Net Loss margin of (7.5%) FY2024 Adjusted EBITDA[1] from Continuing Operations of
- 1y agoZIMVZimVie to Report Fourth Quarter and Full-Year 2024 Financial Results on February 26, 2025GlobeNewswirePALM BEACH GARDENS, Fla., Feb. 12, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the fourth quarter and
- 1y agoZIMVZimVie Announces Publication of a Study Supporting the Benefits of Its Implant Surface TechnologiesGlobeNewswirePALM BEACH GARDENS, Fla., Jan. 30, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental implant market, today announced the publication of a detailed scientific study
- 2y agoZIMVZimVie Inc (ZIMV) Q3 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoZIMVZimVie Reports Third Quarter 2024 Financial ResultsGlobeNewswireThird Party Net Sales from Continuing Operations of $103.2 millionNet Loss from Continuing Operations of $(3.0) million; Net Loss margin of (3.0%) Adjusted EBITDA[1] from Continuing Operations of $13.1 million; Adjusted
- 2y agoZIMVZimVie to Present at the UBS Global Healthcare ConferenceGlobeNewswirePALM BEACH GARDENS, Fla., Oct. 29, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced management will participate in the upcoming UBS Global
- 2y agoZIMVZimVie to Report Third Quarter Financial Results on October 30, 2024GlobeNewswirePALM BEACH GARDENS, Fla., Oct. 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the third quarter 2024
- 2y agoZIMVZimVie Inc. (ZIMV) Q2 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoZIMVZimVie Reports Second Quarter 2024 Financial ResultsGlobeNewswireThird Party Net Sales from Continuing Operations of $116.8 millionNet Loss from Continuing Operations of $(9.6) million; Net Loss margin of (8.2%) Adjusted EBITDA[1] from Continuing Operations of $16.1 million; Adjusted
- 2y agoZIMVZimVie Announces the Release of RealGUIDE® 5.4 Software UpdateGlobeNewswirePALM BEACH GARDENS, Fla., July 31, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced the release of its RealGUIDE® 5.4 software. The update is
- 2y agoZIMVZimVie Announces FDA Clearance and U.S. Launch of GenTek® Restorative ComponentsGlobeNewswirePALM BEACH GARDENS, Fla., July 23, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced the U.S. launch of its GenTek® Genuine Restorative
- 2y agoZIMVZimVie to Report Second Quarter Financial Results on August 1, 2024GlobeNewswirePALM BEACH GARDENS, Fla., July 18, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the second quarter 2024
- 2y agoZIMVZimVie to Participate in Upcoming Investor ConferencesGlobeNewswirePALM BEACH GARDENS, Fla., May 16, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced that the company will be participating in two upcoming investor
- 2y agoZIMVZimVie Inc. (ZIMV) Q1 2024 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoZIMVZimVie Reports First Quarter 2024 Financial ResultsGlobeNewswireThird Party Net Sales from Continuing Operations of $118.2 millionNet Loss from Continuing Operations of ($11.5) million; Net Loss margin of (9.7%) Adjusted EBITDA[1] from Continuing Operations of $12.5 million; Adjusted
- 2y agoZIMVZimVie to Report First Quarter Financial Results on May 8, 2024GlobeNewswirePALM BEACH GARDENS, Fla., April 24, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental market, today announced it will report financial results for the first quarter 2024
- 2y agoZIMVZimVie to Participate in the 23rd Annual Needham Virtual Healthcare ConferenceGlobeNewswireWESTMINSTER, Colo., March 27, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced management will participate in the upcoming 23rd Annual
- 2y agoZIMVZimVie Inc. (ZIMV) Q4 2023 Earnings Call TranscriptEarnings Call Transcripts
- 2y agoZIMVZimVie Reports Fourth Quarter and Full Year 2023 Financial ResultsGlobeNewswireFY 2023 Third Party Net Sales from Continuing Operations of $457.2 millionFY 2023 Third Party Net Sales from Discontinued Operations of $409.2 millionUpdated Reporting Framework: Continuing Operations consists of the
- 2y agoZIMVZimVie Announces Launch of Next-Generation TSX® Implant in JapanGlobeNewswireWESTMINSTER, Colo., Feb. 07, 2024 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced the launch of the TSX® Implant in Japan. As ZimVie's
- 2y agoZIMVZimVie Announces Definitive Agreement to Sell Spine Business to H.I.G. Capital for $375 MillionGlobeNewswireProposed Sale Establishes a Pure-Play Dental Company with a Leading Implant Portfolio Net Proceeds Will be Used to Pay Down Debt and Support Dental Growth Initiatives WESTMINSTER, Colo., Dec. 18, 2023 (GLOBE
- 2y agoZIMVZimVie Announces Compatibility Between its Vital™ Spinal Fixation System and Brainlab Spine & Trauma NavigationGlobeNewswireWESTMINSTER, Colo., Dec. 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced it has received FDA clearance for its Vital™ Spinal
- 3y agoZIMVZimVie Reports Third Quarter 2023 Financial Results and Provides Update to Annual GuidanceGlobeNewswireThird Party Net Sales of $202.9 millionNet Loss of ($5.1) million; Net Loss Margin of (2.5%); Adjusted Net Income[1] of $2.2 millionDiluted EPS of ($0.19); Adjusted Diluted EPS[1] of $0.08Adjusted EBITDA[1] of $25.8
- 3y agoZIMVZimVie Announces First U.S. Surgery with the 4.5mm Mobi-C® Cervical DiscGlobeNewswireWESTMINSTER, Colo., Oct. 31, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that the first patient in the United States has received
- 3y agoZIMVZimVie Announces Over 2,000 Children Have Received The Tether™ VBTGlobeNewswireWESTMINSTER, Colo., Oct. 24, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that over 2,000 children worldwide have been treated with
- 3y agoZIMVZimVie Announces the Launch of Azure™ Multi-Platform Product SolutionsGlobeNewswireWESTMINSTER, Colo., Oct. 17, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of Azure™ Multi-Platform Product
- 3y agoZIMVZimVie to Report Third Quarter 2023 Financial Results on November 1, 2023GlobeNewswireWESTMINSTER, Colo., Oct. 11, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the third quarter 2023
- 3y agoZIMVZimVie Announces the Recent Launch of Biotivity™ A/C Plus MembraneGlobeNewswireWESTMINSTER, Colo., Oct. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launch of the Biotivity™ A/C Plus
- 3y agoZIMVZimVie Announces FDA Approval to Launch Mobi-C® Hybrid StudyGlobeNewswireWESTMINSTER, Colo., Sept. 26, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that on September 7, 2023, the U.S. Food and Drug
- 3y agoZIMVZimVie Expands Development Cooperation Agreement with Brainlab AG to Include Co-MarketingGlobeNewswireZimVie and Brainlab will cooperate on achieving compatibility between ZimVie's Vital™ and Virage® fixation systems with the Brainlab spine and trauma technologies for global co-marketing purposes
- 3y agoZIMVZimVie Announces FDA Approval for New Mobi-C® ImplantGlobeNewswireWESTMINSTER, Colo., Aug. 10, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that on August 1st, 2023, the U.S. Food and Drug
- 3y agoZIMVZimVie Reports Second Quarter 2023 Financial Results and Provides Update to Annual GuidanceGlobeNewswireThird Party Net Sales of $224.9 millionNet Loss of ($23.4) million; Net Loss Margin of (10.4%); Adjusted Net Income[1] of $4.3 millionDiluted EPS of ($0.89); Adjusted Diluted EPS[1] of $0.17Adjusted EBITDA[1] of $29.7
- 3y agoZIMVZimVie to Report Second Quarter 2023 Financial Results on August 2, 2023GlobeNewswireWESTMINSTER, Colo., July 12, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, announced it will report financial results for the second quarter 2023
- 3y agoZIMVZimVie to Present at the Stifel 2023 Jaws & Paws ConferenceGlobeNewswireWESTMINSTER, Colo., May 22, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced that the company will be participating in the upcoming
- 3y agoZIMVZimVie Reports First Quarter 2023 Financial Results and Provides Update to Annual GuidanceGlobeNewswireThird Party Net Sales of $225.1 million Net Loss of ($30.0) million; Net Loss Margin of (13.3%); Adjusted Net Income[1] of $6.7 millionDiluted EPS of ($1.14); Adjusted Diluted EPS[1] of $0.25Adjusted EBITDA[1] of $32.1
- 3y agoZIMVZimVie Opens State-of-the-Art Dental Science Educational and Training Institute in Palm Beach Gardens, FloridaGlobeNewswireWESTMINSTER, Colo., April 27, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced the opening of its new, state-of-the-art educational
- 3y agoZIMVZimVie Announces the Recent Launches of RegenerOss® CC Allograft Particulate and RegenerOss® Bone Graft PlugGlobeNewswireWESTMINSTER, Colo., April 13, 2023 (GLOBE NEWSWIRE) -- ZimVie Inc. (NASDAQ:ZIMV), a global life sciences leader in the dental and spine markets, today announced the recent launches of two additions to its biomaterials